International consensuses and guidelines on management of proliferative diabetic retinopathy (PDR) by the Asia-Pacific Vitreo-retina Society (APVRS), the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO) and the Academia Retina Internationalis (ARI)
Asia-Pacific Journal of Ophthalmology · 2025
DOI: 10.1016/j.apjo.2025.100262 ↗Kurz gefasst
Leitlinie in der Zeitschrift Asia-Pacific Journal of Ophthalmology, 2025. Verfasst von Robert F Lam und 25 weiteren Autor:innen. Beteiligte Einrichtung: The Primasia International Eye Research Institute (PIERI) of The Chinese University of Hong Kong (Shenzhen), Shenzhen, China; The C-MER Dennis Lam & …. Hauptthemen laut MEDLINE: Consensus, Diabetic Retinopathy, Disease Management, Ophthalmology. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Institute for Information and Communications Technology Promotion, Ministry of Health and Welfare, Korea Health Industry Development Institute.
Abstract (Originalsprache)
The management of proliferative diabetic retinopathy (PDR) presents both established consensus and ongoing controversies, particularly regarding emerging therapies (anti-vascular endothelial growth factor agents [VEGF], subthreshold laser and intravitreal steroids) versus conventional approaches (laser photocoagulation and vitrectomy). The Asia-Pacific Vitreo-retina Society (APVRS), the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO) and the Academia Retina Internationalis (ARI) saw such a need to establish consensus and controversial statements on PDR management. They formed an international panel of experts (IPE) comprising 26 experts from 13 countries/territories to establish the statements, including diagnosis and diagnostic technologies, screening approaches, laser, anti-VEGF, intravitreal steroids and vitrectomy and related techniques in PDR management. The objective is to synthesize evidence-based real-world practice recommendations from leading global experts to guide the management of PDR. Of the 37 statements, the IPE reached consensus (75 % voted as "Strong Agreement" or "Agreement") on 28 (76 %) statements. Controversial statements, such as panretinal photocoagulation (PRP) in special scenarios, use of steroids in cases unresponsive to anti-VEGF and PRP and during vitrectomy to improve visual oucomes, and specific surgical techniques such as internal limiting membrane peeling and drainage retinotomy in the treatment of PDR are identified. Given its high prevalence and propensity for visual morbidity, and the recent advances in surgery for PDR, confirming the standard practices and deliberating on controversies to find the best approach by international experts would help improve the management of PDR further.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Primasia International Eye Research Institute (PIERI) of The Chinese University of Hong Kong (Shenzhen), Shenzhen, China; The C-MER Dennis Lam & Partners Eye Center, C-MER International Eye Care Group, Hong Kong, Ch…
- The Primasia International Eye Research Institute (PIERI) of The Chinese University of Hong Kong (Shenzhen), Shenzhen, China; Eye Department, C+ Health CKJ (Shenzhen) Hospital, Luohu, Shenzhen, China.
- Eye Clinic, San Raffaele Hospital, Vita-Salute University, Milan, Italy.
- Medical Research Foundation, Sankara Nethralaya, Chennai, India.
- Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou, Taiwan; Department of Ophthalmology, New Taipei Municipal Tucheng Hospital, New Taipei City, Taiwan; College of Medicine, Chang Gung University, Taoyuan…
- Singapore Eye Research Institute, Singapore National Eye Centre, Singapore; Ophthalmology & Visual Sciences Academic Clinical Program (Eye ACP), Duke-NUS Medical School, Singapore.
Förderung
- Institute for Information and Communications Technology Promotion
- Ministry of Health and Welfare
- Korea Health Industry Development Institute
- Ministry of Science and ICT, South Korea
- Information Technology Research Centre
- National Research Foundation of Korea
- Chinese University of Hong Kong
Zitieren
APA
Lam, R. F., Radke, N. V., Bandello, F. M., Bhende, P., Chen, Y. T., Cheung, G. C. M., Chhablani, J., Fung, A. T., Hsieh, Y. T., Lai, C. C., Lee, V. Y. W., Li, X., Li, T., Lim, J. I., Mieler, W. F., Nanegrungsunk, O., Park, D. H., Peto, T., Raman, R., …, & Lam, D. S. C. (2025). International consensuses and guidelines on management of proliferative diabetic retinopathy (PDR) by the Asia-Pacific Vitreo-retina Society (APVRS), the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO) and the Academia Retina Internationalis (ARI). Asia-Pacific Journal of Ophthalmology. https://doi.org/10.1016/j.apjo.2025.100262
Vancouver
Lam RF, Radke NV, Bandello FM, Bhende P, Chen YT, Cheung GCM, et al. International consensuses and guidelines on management of proliferative diabetic retinopathy (PDR) by the Asia-Pacific Vitreo-retina Society (APVRS), the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO) and the Academia Retina Internationalis (ARI). Asia-Pacific Journal of Ophthalmology. 2025. doi:10.1016/j.apjo.2025.100262
BibTeX
@article{Lam2025,
author = {Lam, Robert F and Radke, Nishant V and Bandello, Francesco M and Bhende, Pramod and Chen, Yen-Ting and Cheung, Gemmy C M and Chhablani, Jay and Fung, Adrian T and Hsieh, Yi-Ting and Lai, Chi-Chun and Lee, Vincent Y W and Li, Xiaorong and Li, Tao and Lim, Jennifer I and Mieler, William F and Nanegrungsunk, Onnisa and Park, Dong Ho and Peto, Tunde and Raman, Rajiv and Ruamviboonsuk, Paisan and Sharma, Tarun and Wang, Zhaoyang and Xu, Xun and Yoshida, Shigeo and Chang, Andrew and Lam, Dennis S C},
title = {International consensuses and guidelines on management of proliferative diabetic retinopathy (PDR) by the Asia-Pacific Vitreo-retina Society (APVRS), the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO) and the Academia Retina Internationalis (ARI)},
journal = {Asia-Pacific Journal of Ophthalmology},
year = {2025},
doi = {10.1016/j.apjo.2025.100262}
}
EUVIMED